1921
Volume 101, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We report two unusual cases of clinical strongyloidiasis that present as extensive thrombosis: a case of hyperinfection with concurrent eosinophilia and a case of disseminated infection as a complication of immunosuppression. We discuss risk factors for the development of infection and thromboembolism, and the recommended management.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0347
2019-06-17
2020-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/2/tpmd190347.html?itemId=/content/journals/10.4269/ajtmh.19-0347&mimeType=html&fmt=ahah

References

  1. Boggild AK, Libman M, Greenway C, McCarthy AE, 2016. CATMAT statement on disseminated strongyloidiasis: prevention, assessment and management guidelines. Can Commun Dis Rep 42: 1219.
    [Google Scholar]
  2. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC, 2004. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 171: 479484.
    [Google Scholar]
  3. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, Vounatsou P, Odermatt P, 2013. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7: 2288.
    [Google Scholar]
  4. Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, Joya-Harrison J, Rodriguez D, 2017. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolysis 44: 377385.
    [Google Scholar]
  5. Tichelaar YI, Kluin-Nelemans HJ, Meijer K, 2012. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost 107: 827837.
    [Google Scholar]
  6. van Zaane B, Nur E, Squizzato A, Gerdes VE, Büller HR, Dekkers OM, Brandjes DP, 2010. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost 8: 24832493.
    [Google Scholar]
  7. Johannesdottir SA, Horváth-Puhó E, Dekkers OM, Cannegieter SC, Jørgensen JO, Ehrenstein V, Vandenbroucke JP, Pedersen L, Sørensen HT, 2013. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173: 743752.
    [Google Scholar]
  8. Ogbogu PU, Rosing DR, Horne MK, 2007. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 27: 457475.
    [Google Scholar]
  9. Maino A, Rossio R, Cugno M, Marzano AV, Tedeschi A, 2012. Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol 10: 670675.
    [Google Scholar]
  10. Ames PR, Aloj G, Gentile F, 2011. Eosinophilia and thrombosis in parasitic diseases: an overview. Clin Appl Thromb Hemost 17: 3338.
    [Google Scholar]
  11. Filkins LM, Gaston DC, Mathison B, Smith T, Couturier MR, Murphy RD, Ciarkowski C, Hanson KE, Cariello PF, 2017. Biliary Strongyloides stercoralis with cholecystitis and extensive portal vein thrombosis. Open Forum Infect Dis 4: 217.
    [Google Scholar]
  12. Sarangi S, Phillips SD, Burkhart HM, 2013. Strongyloides-associated left ventricular thrombus. Ann Thorac Surg 96: 1487.
    [Google Scholar]
  13. Kearon C et al., 2012. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: 419496.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0347
Loading
/content/journals/10.4269/ajtmh.19-0347
Loading

Data & Media loading...

  • Received : 05 May 2019
  • Accepted : 14 May 2019
  • Published online : 17 Jun 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error